Session Details
[3TS11a]MC and BC, Disease 2
Fri. Jul 26, 2024 2:50 PM - 4:50 PM JST
Fri. Jul 26, 2024 5:50 AM - 7:50 AM UTC
Fri. Jul 26, 2024 5:50 AM - 7:50 AM UTC
Room 11 409
Senior Discussant: Takahiro Masuda (Medical Institute of Bioregulation, Kyushu University), Norihisa Bizen (Graduate School of Medical and Dental Sciences, Niigata University)
Young Chair: Mami Matsumoto (Department of Developmental and Regenerative Neurobiology, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences)
Young Chair: Mami Matsumoto (Department of Developmental and Regenerative Neurobiology, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences)
[3TS11a-01]Deficiency of the phosphatase Ctdenp1 causes amyotrophic lateral sclerosis-like symptoms in mice.
*Yuta Kimura1, Chisato Sampei1, Yasuhiro Arasaki1, Yukihiro Kohara1, Ryuichi Nishinakamura2, Tadayoshi Hayata1 (1. Grad. Sch of Pharm. Sci., Tokyo Univ. of Sci., Chiba, Japan, 2. IMEG, Kumamoto Univ., Kumamoto, Japan)
[3TS11a-02]Spinal cord motor neuron phenotypes and polygenic risk scores in sporadic ALS: deciphering disease pathology and therapeutic potential of ropinirole hydrochloride
*Chris Kato1, Satoru Morimoto1, Shinichi Takahashi1,2, Shinichi Namba3, Qingbo Seiha Wang3,4,5, Yukinori Okada3,4,5,6,7,8, Hideyuki Okano1 (1. Keio University, 2. Department of Neurology and Stroke, Saitama Medical University International Medical Center, 3. Department of Statistical Genetics, Osaka University Graduate School of Medicine, 4. Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, 5. Department of Genome Informatics, Graduate School of Medicine, The University of Tokyo, 6. Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, 7. Center for Infectious Disease Education and Research (CiDER), Osaka University, 8. Laboratory for Systems Genetics, RIKEN Center for Integrative Medical Sciences)
[3TS11a-03]Establishing a mouse model of degenerative cervical myelopathy and effects of acteoside on neurological disabilities in the model
*Keigo Hashiba1, Chihiro Tohda1 (1. Section of Neuromedical Science, Inst. of Natural Med., Univ. of Toyama)
[3TS11a-04]Knockdown of drug efflux transporter MRP5 showed neurotoxicity accompanied by regulation of a neurotransmitter
*Maki Watanabe1, Takahiro Ishimoto1, Shoma Yamada1, Yusuke Masuo1, Yukio Kato1 (1. Faculty of Pharmacy, Kanazawa University)